Related Experiment Video
Updated: Aug 26, 2026
Preparation and Characterization of Individual and Multi-drug Loaded Physically Entrapped Polymeric Micelles
Published on: August 28, 2015
[Preliminary study on preparation and pharmaceutic features of adrimycin-loaded human serum albumin microspheres]
Xiao-bo Liu1, Mei-ying Cai, Yan Gong
1Immunology Department, West China School of Preclinical and Forensic Medicine, Sichuan University, Chengdu 610041, China.
Objective:
To prepare adrimycin-loaded human serum albumin microspheres(ADR-HSA-MS) and to study its pharmaceutic properties and in vitro cytotoxicity.
Methods:
ADR-HSA-MS, consisting of ADR and HSA, were prepared by emulsion heating solidification method and its morphology was observed by optical microscopy and scanning electron microscopy. Pepsin digestion method was used for determining drug loading of ADR-HSA-MS and membrane diffusion technique for detection of in vitro release of ADR from the microspheres. MTT colorimetric assay was used to determine cytotoxicity of ADR-HSA-MS for human hepatoma SMMC-7721 cell line.
Results:
ADR-HSA-MS looked like smooth red spheres with an average diameter of 1.2 microns and had an apparent drug-loading of 2.73% or an effective drug-loading of 1.69%. Its peak of the accumulated drug-releasing fraction was 65%, and 50% of ADR releasing from the MS would take five days, which suggested a slow release of ADR from the albumin microspheres. ADR-HSA-MS exerted remarkable cytotoxicity to human hepatoma SMMC-7721 cells with dose-dependence at a range of ADR concentration from 0.3 microgram/ml to 2.5 micrograms/ml when incubated with the target cells for four days. Its killing curve was similar to that of free ADR.
Conclusion:
Emulsion heating solidification method could be used for preparation of adrimycin-loaded human serum albumin microspheres with sustained release property.
Insights
Researchers developed adrimycin-loaded human serum albumin microspheres (ADR-HSA-MS) with sustained release properties. These microspheres demonstrated significant, dose-dependent cytotoxicity against human hepatoma cells, similar to free adrimycin.
Area of Science:
- Biomedical Engineering
- Materials Science
- Pharmacology
Context:
- Developing novel drug delivery systems is crucial for improving cancer therapy efficacy.
- Human serum albumin (HSA) is a biocompatible and biodegradable material suitable for nanoparticle formulation.
- Microsphere formulations offer potential for controlled drug release and targeted delivery.
Purpose:
- To synthesize adrimycin-loaded human serum albumin microspheres (ADR-HSA-MS).
- To characterize the pharmaceutical properties, including drug loading and in vitro release kinetics.
- To evaluate the in vitro cytotoxicity of ADR-HSA-MS against human hepatoma cells.
Summary:
- ADR-HSA-MS were prepared using an emulsion heating solidification method, resulting in smooth, spherical particles with an average diameter of 1.2 microns.
- The microspheres exhibited an effective drug loading of 1.69% and a sustained release profile, with 50% of adrimycin released over five days.
- ADR-HSA-MS demonstrated dose-dependent cytotoxicity against SMMC-7721 hepatoma cells, comparable to free adrimycin.
Impact:
- The study validates the emulsion heating solidification method for producing sustained-release ADR-HSA-MS.
- The findings suggest ADR-HSA-MS as a promising platform for adriamycin delivery in hepatoma treatment.
- Further research may explore in vivo efficacy and therapeutic potential of these microspheres.
